A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.
List view / Grid view
Filter the results
A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.
Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
New research into sex-based differences of Parkinson's disease could lead to new treatments.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
Imaging methods are used by scientists to identify therapeutic targets and improve drug efficacy. This article lists five of the latest developments for imaging techniques.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
Scientists have found a way to target and knock out a protein which is widely involved in pancreatic cancer cell growth, survival and invasion.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.